These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35385594)

  • 1. Food and Drug Administration perspective: Advancing product development for non-healing chronic wounds.
    Verma KD; Lewis F; Mejia M; Chalasani M; Marcus KA
    Wound Repair Regen; 2022 May; 30(3):299-302. PubMed ID: 35385594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-based biomaterials for chronic wound management: Promises and challenges.
    Maaz Arif M; Khan SM; Gull N; Tabish TA; Zia S; Ullah Khan R; Awais SM; Arif Butt M
    Int J Pharm; 2021 Apr; 598():120270. PubMed ID: 33486030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Drugs of Uncertain Value, Lifecycle Regulation at the US Food and Drug Administration, and Institutional Incumbency.
    Herder M
    Milbank Q; 2019 Sep; 97(3):820-857. PubMed ID: 31407412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and content validation of wound therapy clinical endpoints relevant to clinical practice and patient values for FDA approval. Part 1. Survey of the wound care community.
    Driver VR; Gould LJ; Dotson P; Gibbons GW; Li WW; Ennis WJ; Kirsner RS; Eaglstein WH; Bolton LL; Carter MJ
    Wound Repair Regen; 2017 May; 25(3):454-465. PubMed ID: 28370922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus.
    Armstrong DG; Boulton AJ; Andros G; Attinger C; Eisenbud D; Lavery LA; Lipsky BA; Mills JL; Sibbald G; Smith AP; Wukich D; Margolis DJ
    Int Wound J; 2009 Jun; 6(3):211-3. PubMed ID: 19538193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence supporting wound care end points relevant to clinical practice and patients' lives. Part 2. Literature survey.
    Driver VR; Gould LJ; Dotson P; Allen LL; Carter MJ; Bolton LL
    Wound Repair Regen; 2019 Jan; 27(1):80-89. PubMed ID: 30315716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.
    Romero K; Sinha V; Allerheiligen S; Danhof M; Pinheiro J; Kruhlak N; Wang Y; Wang SJ; Sauer JM; Marier JF; Corrigan B; Rogers J; Lambers Heerspink HJ; Gumbo T; Vis P; Watkins P; Morrison T; Gillespie W; Gordon MF; Stephenson D; Hanna D; Pfister M; Lalonde R; Colatsky T
    J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):545-52. PubMed ID: 25288257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for enhancing angiogenesis in wound healing.
    Veith AP; Henderson K; Spencer A; Sligar AD; Baker AB
    Adv Drug Deliv Rev; 2019 Jun; 146():97-125. PubMed ID: 30267742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of Chronic Wounds: An Update of Recent Developments and Future Possibilities.
    Kathawala MH; Ng WL; Liu D; Naing MW; Yeong WY; Spiller KL; Van Dyke M; Ng KW
    Tissue Eng Part B Rev; 2019 Oct; 25(5):429-444. PubMed ID: 31068101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects.
    Shao M; Hussain Z; Thu HE; Khan S; de Matas M; Silkstone V; Qin HL; Bukhari SNA
    Crit Rev Ther Drug Carrier Syst; 2017; 34(5):387-452. PubMed ID: 29256838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in wound care products: a FDA regulatory perspective.
    Chang CJ; Kazemzadeh-Narbat M
    J Wound Care; 2021 Feb; 30(Sup2):S3-S4. PubMed ID: 33573498
    [No Abstract]   [Full Text] [Related]  

  • 15. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U.S. Food and Drug Administration's role in improving radiation dose management for medical X-ray imaging devices.
    Miller DL; Kakar S; Jiang L; Spelic DC; Burk L
    Br J Radiol; 2021 Oct; 94(1126):20210373. PubMed ID: 33989043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in inorganic nanomaterials for wound-healing applications.
    Nethi SK; Das S; Patra CR; Mukherjee S
    Biomater Sci; 2019 Jul; 7(7):2652-2674. PubMed ID: 31094374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wound Healing Driver Gene and Therapeutic Development: Political and Scientific Hurdles.
    Tang X; Hao M; Chang C; Bhatia A; O'Brien K; Chen M; Armstrong DG; Li W
    Adv Wound Care (New Rochelle); 2021 Aug; 10(8):415-435. PubMed ID: 32966158
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient Experience Data in US Food and Drug Administration (FDA) Regulatory Decision Making:: A Policy Process Perspective.
    Kuehn CM
    Ther Innov Regul Sci; 2018 Sep; 52(5):661-668. PubMed ID: 29714560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.